Left Ventricular Assist Device Market Scope And Analysis

  • Report Code : TIPRE00018950
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 159
Buy Now

Left Ventricular Assist Device Market Scope, Growth, Size and Share by 2028

Buy Now

Left Ventricular Assist Device Market Report Left Ventricular Assist Device Market Size and Share Left Ventricular Assist Device Market Scope and Analysis

Left Ventricular Assist Device Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.27 Billion
Market Size by 2028 US$ 1.81 Billion
Global CAGR (2021 - 2028) 5.1%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type of Flow
  • Pulsatile and Non-Pulsatile
By Design
  • Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices
By Application
  • Bridge-to-Transplantation
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge-to-Candidacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ABIOMED Inc
  • Abbott Laboratories
  • Medtronic Plc
  • LivaNova Plc
  • Jarvik Heart Inc
  • Terumo Corp
  • Berlin Heart GmbH
  • BiVACOR Inc
  • Evaheart Inc

    • Company-Based Insights

    ABIOMED Inc, Abbott Laboratories, Medtronic Plc, LivaNova Plc, Jarvik Heart Inc, Terumo Corp, Berlin Heart GmbH, BiVACOR Inc, Evaheart Inc, and BioVentrix Inc. are among the leading companies operating in the left ventricular assist device market.